Chemomab Therapeutics Ltd. Earnings Per Share, Basic and Diluted
Chemomab Therapeutics Ltd. (CMMB) reported Earnings Per Share, Basic and Diluted of $0.02 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for the quarter ending 2022-03-31 was $0.02, a 100.00% increase year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.02.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for the quarter ending 2021-09-30 was $0.01, a 44.44% increase year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for the quarter ending 2021-06-30 was $0.01, a 62.50% increase year-over-year.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for fiscal 2021 was $0.06, a 36.36% increase from fiscal 2020.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for fiscal 2020 was $0.04, a 94.43% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for fiscal 2019 was $0.79, a 27.52% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. earnings per share, basic and diluted for fiscal 2018 was $1.09.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | $0.02 10-Q · filed 2022-05-12 | -$0.04 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-28 | ||||
| 2021-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-03-28 | $0.06 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | $0.01 10-Q · filed 2021-11-12 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-11-10 | $0.04 10-Q · filed 2021-11-12 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||||
| 2021-06-30 | $0.01 10-Q · filed 2021-08-13 | $0.02 10-Q · filed 2021-08-13 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.05 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||||
| 2021-03-31 | $0.01 10-Q · filed 2022-05-12 | -$0.02 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.04 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||||
| 2020-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-30 | $0.04 10-K · filed 2022-03-30 | $0.31 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $0.01 10-Q · filed 2021-11-12 | -$0.07 10-Q · filed 2020-11-16 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-11-12 | $0.03 10-Q · filed 2021-11-12 | -$0.26 10-Q · filed 2020-11-16 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-11-12 | ||
| 2020-06-30 | $0.01 10-Q · filed 2021-08-13 | -$0.09 10-Q · filed 2020-08-14 | $0.02 10-Q · filed 2021-08-13 | -$0.19 10-Q · filed 2020-08-14 | -$0.16 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-11-12 | ||
| 2020-03-31 | $0.01 10-Q · filed 2021-05-13 | -$0.10 10-Q · filed 2020-05-07 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.65 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.73 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2019-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2021-03-09 | $0.40 derived: net income ÷ weighted average shares · filed 2021-03-09 | $1.96 derived: net income ÷ weighted average shares · filed 2021-03-09 | $0.79 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | -$0.19 10-Q · filed 2020-11-16 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.64 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | -$0.12 10-Q · filed 2020-08-14 | -$0.45 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | -$0.38 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $1.09 10-K · filed 2020-03-17 |